Dostinex Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The global dostinex market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Dostinex is a dopamine receptor antagonist used to treat high levels of prolactin hormone in the body. The rise in the prevalence of PD is anticipated to drive the growth of the global dostinex market. According to Parkinson’s’ foundation statistics, approximately more than 10 million people are living with PD globally. Approximately 1 million people in the US are living with PD and 60,000 Americans are diagnosed with PD annually. The incidence of PDincreases with the age, where an estimated 4.0% of people with PD are diagnosed before age of 50. Further, the Parkinson’s Foundation Project estimated that 930,000 people suffered from Parkinson’s disease in 2020, and is estimated to rise to 1.2 million by 2030. Additionally, according to the Global Burden of Disease Study, 6.2 million patients live with PD and the frequency is anticipated to double by 2040.

The rise in the prevalence of hyperprolactinemia is further anticipated to drive the growth of the global dostinex market. For instance, according to the data published by National Center for Biotechnology Information (NCBI) in 2021, hyperprolactinemia is anticipated to occur in 1.0% of the population and 5.0% to 14.0% of patients presenting secondary amenorrhea. The most common type is a prolactin-secreting tumor registering up to 40.0% of all clinically recognized pituitary adenomas. Moreover, the prevalence of prolactinoma is estimated at around 30 per 100,000 in women and 10 per 100,000 in men, with a peak prevalence in women aged 25 to 34 years. Thus, the rise in the prevalence of hyperprolactinemia is projected to accelerate the demand for the global dostinex market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Ltd., and Mylan (Vitaris Inc.) among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Dostinex Market Report by Segment

By Type

• 25mg
• 75mg
• Others

By Application

• Parkinson’s Disease
• Hyperprolactinemia